OPK Logo

OPKO Health, Inc. (OPK) 

NASDAQ
Market Cap
$1.05B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
43 of 960
Rank in Industry
3 of 52

Largest Insider Buys in Sector

OPK Stock Price History Chart

OPK Stock Performance

About OPKO Health, Inc.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers …

Insider Activity of OPKO Health, Inc.

Over the last 12 months, insiders at OPKO Health, Inc. have bought $11.95M and sold $0 worth of OPKO Health, Inc. stock.

On average, over the past 5 years, insiders at OPKO Health, Inc. have bought $9.56M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: FROST PHILLIP MD ET AL (CEO & Chairman) — $87.01M. Zerhouni Elias A. (Vice Chairman and President) — $1.03M. HSIAO JANE PH D (Vice Chairman & CTO) — $546,797.

The last purchase of 125,000 shares for transaction amount of $199,375 was made by FROST PHILLIP MD ET AL (CEO & Chairman) on 2024‑12‑13.

List of Insider Buy and Sell Transactions, OPKO Health, Inc.

2024-12-13PurchaseCEO & Chairman
125,000
0.0182%
$1.59$199,375+0.63%
2024-12-11PurchaseCEO & Chairman
500,000
0.0713%
$1.56$781,050+0.63%
2024-11-29PurchaseCEO & Chairman
199,072
0.0291%
$1.53$305,376+2.60%
2024-11-22PurchaseCEO & Chairman
100,000
0.0147%
$1.59$159,0000.00%
2024-11-14PurchaseCEO & Chairman
100,000
0.0146%
$1.62$161,980+1.25%
2024-11-08PurchaseCEO & Chairman
280,183
0.0399%
$1.50$421,535+3.95%
2024-05-23PurchaseCEO & Chairman
100,000
0.0142%
$1.27$126,937+17.19%
2024-05-17PurchaseCEO & Chairman
163,997
0.0229%
$1.29$211,195+14.50%
2024-03-18PurchaseCEO & Chairman
500,000
0.0725%
$0.87$437,100+66.96%
2024-03-14PurchaseCEO & Chairman
500,000
0.0693%
$0.89$444,300+62.07%
2024-03-13PurchaseCEO & Chairman
500,000
0.0723%
$0.93$463,750+53.61%
2024-03-12PurchaseCEO & Chairman
600,000
0.0865%
$0.93$559,380+54.11%
2024-02-28PurchaseCEO & Chairman
500,000
0.0718%
$0.99$496,150+43.07%
2024-02-21PurchaseCEO & Chairman
1M
0.1283%
$0.99$991,700+38.61%
2024-02-07PurchaseCEO & Chairman
1.5M
0.1855%
$0.98$1.46M+37.00%
2024-01-29Purchasedirector
30,000
0.0038%
$0.99$29,838+31.40%
2024-01-19PurchaseCEO & Chairman
500,000
0.0634%
$0.98$488,650+35.81%
2024-01-18PurchaseCEO & Chairman
400,000
0.0506%
$0.97$386,200+37.56%
2024-01-17PurchaseVice Chairman & CTO
150,000
0.0187%
$0.95$142,500+37.70%
2024-01-16PurchaseCEO & Chairman
1M
0.1308%
$0.95$954,300+43.19%

Insider Historical Profitability

9.18%
FROST PHILLIP MD ET ALCEO & Chairman
212536477
31.1417%
$1.5411490+10.39%
HSIAO JANE PH DVice Chairman & CTO
27999880
4.1026%
$1.54270+7.49%
Zerhouni Elias A.Vice Chairman and President
20327814
2.9785%
$1.5420<0.0001%
Rubin Steven DExecutive VP-Administration
6187732
0.9066%
$1.54152<0.0001%
PAGANELLI JOHN Adirector
384340
0.0563%
$1.5460<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$39.87M4.7733.23M-10.11%-$4.48M<0.01
The Vanguard Group$35.4M4.2329.5M-25.79%-$12.3M<0.01
State Street$12.24M1.4610.2M+9.63%+$1.08M<0.01
Geode Capital Management$11.97M1.439.97M+2.6%+$302,659.93<0.01
Charles Schwab$6.97M0.835.81M+1.32%+$90,717.60<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.